A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma

Clinical trial NCT00221325 · COMPLETED

Trial details

NCT number: NCT00221325
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Central Nervous System Lymphoma Intraocular Lymphoma

Start date: 2007-04-01
Primary completion: 2012-01-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.